148 related articles for article (PubMed ID: 33520516)
1. Prevalence of Microalbuminuria in Type 2 Diabetes Mellitus.
Sana MA; Chaudhry M; Malik A; Iqbal N; Zakiuddin A; Abdullah M
Cureus; 2020 Dec; 12(12):e12318. PubMed ID: 33520516
[TBL] [Abstract][Full Text] [Related]
2. Microalbuminuria as the Tip of Iceberg in Type 2 Diabetes Mellitus: Prevalence, Risk Factors, and Associated Diabetic Complications.
Asghar S; Asghar S; Mahmood T; Bukhari SMH; Mumtaz MH; Rasheed A
Cureus; 2023 Aug; 15(8):e43190. PubMed ID: 37692611
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with diabetic nephropathy in children, adolescents, and adults with type 1 diabetes.
Huang CY; Ting WH; Lo FS; Tsai JD; Sun FJ; Chan CI; Chiang YT; Lin CH; Cheng BW; Wu YL; Hung CM; Lee YJ
J Formos Med Assoc; 2017 Dec; 116(12):924-932. PubMed ID: 29070437
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Non Alcoholic Fatty Liver Disease and its Association with Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus.
Heidari Z; Gharebaghi A
J Clin Diagn Res; 2017 May; 11(5):OC04-OC07. PubMed ID: 28658824
[TBL] [Abstract][Full Text] [Related]
5. Serum VEGF as a predictive marker of glycemic control and diabetic nephropathy in Chinese older adults with type 2 diabetes mellitus.
Jiang Y; Li J; Zhang J; Chen S
Front Endocrinol (Lausanne); 2023; 14():1274025. PubMed ID: 38075072
[TBL] [Abstract][Full Text] [Related]
6. [Change and significance of urinary smad3 in type 2 diabetic nephropathy].
Guo KF; Kou JX; Lu JX; Zhang L; Yu HY; Chen HB
Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1067-71. PubMed ID: 23902838
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of microalbuminuria with relation to glycemic control in type-2 diabetic patients in Karachi.
Sheikh SA; Baig JA; Iqbal T; Kazmi T; Baig M; Husain SS
J Ayub Med Coll Abbottabad; 2009; 21(3):83-6. PubMed ID: 20929021
[TBL] [Abstract][Full Text] [Related]
8. An observational, cross-sectional study to assess the prevalence of chronic kidney disease in type 2 diabetes patients in India (START -India).
Prasannakumar M; Rajput R; Seshadri K; Talwalkar P; Agarwal P; Gokulnath G; Kotak B; Raza A; Vasnawala H; Teli C
Indian J Endocrinol Metab; 2015; 19(4):520-3. PubMed ID: 26180769
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and risk factors of diabetic nephropathy among Thai patients with type 2 diabetes mellitus.
Krairittichai U; Potisat S; Jongsareejit A; Sattaputh C
J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S1-5. PubMed ID: 21717870
[TBL] [Abstract][Full Text] [Related]
10. Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial.
Cherney DZI; Zinman B; Inzucchi SE; Koitka-Weber A; Mattheus M; von Eynatten M; Wanner C
Lancet Diabetes Endocrinol; 2017 Aug; 5(8):610-621. PubMed ID: 28666775
[TBL] [Abstract][Full Text] [Related]
11. Effect of glycemic control on microalbuminuria development among type 2 diabetes with high-normal albuminuria.
Chen WZ; Hung CC; Wen YW; Ning HC; Gau BR; Huang YY
Ren Fail; 2014 Mar; 36(2):171-5. PubMed ID: 24028605
[TBL] [Abstract][Full Text] [Related]
12. Does serum kidney injury molecule-1 predict early diabetic nephropathy: A comparative study with microalbuminuria.
Balu D; Krishnan V; Krishnamoorthy V; Singh RBS; Narayanasamy S; Ramanathan G
Ann Afr Med; 2022; 21(2):136-139. PubMed ID: 35848645
[TBL] [Abstract][Full Text] [Related]
13. Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
Elsheikh M; Elhefnawy KA; Emad G; Ismail M; Borai M
J Bras Nefrol; 2019; 41(4):509-517. PubMed ID: 30897192
[TBL] [Abstract][Full Text] [Related]
14. Association of diabetic nephropathy with the severity of obstructive sleep apnea-hypopnea syndrome in patients with type 2 diabetes mellitus.
Dong M; Guo F; Zhou T; Wei Q
Endocr J; 2020 May; 67(5):515-522. PubMed ID: 32023571
[TBL] [Abstract][Full Text] [Related]
15. The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes.
Cherney D; Lund SS; Perkins BA; Groop PH; Cooper ME; Kaspers S; Pfarr E; Woerle HJ; von Eynatten M
Diabetologia; 2016 Sep; 59(9):1860-70. PubMed ID: 27316632
[TBL] [Abstract][Full Text] [Related]
16. Microalbuminuria and Traditional Serum Biomarkers of Nephropathy among Diabetic Patients at Mbarara Regional Referral Hospital in South Western Uganda.
Kiconco R; Rugera SP; Kiwanuka GN
J Diabetes Res; 2019; 2019():3534260. PubMed ID: 31934589
[TBL] [Abstract][Full Text] [Related]
17. Urine transferrin as an early endothelial dysfunction marker in type 2 diabetic patients without nephropathy: a case control study.
Sánchez-Hidalgo JJ; Suárez-Cuenca JA; Lozano-Nuevo JJ; García-López VH; Leal-Gutiérrez MG; León-Angel SA; Ramírez-Villa ML; Rodea-Rubio ME; González-Hernández JE; Canela-Mayoral JA; Murillo-Heredia E; Vera-Gómez E; Hernández-Patricio A; Zamora-Alemán CR; Domínguez-Pérez GA; Gutiérrez-Buendia JA; Mondragón-Terán P
Diabetol Metab Syndr; 2021 Nov; 13(1):128. PubMed ID: 34743740
[TBL] [Abstract][Full Text] [Related]
18. [Urinary retinol binding protein and β
Li SM; Wang YA; Liu W; Wu ZY; Chen L; Cai XL; Zhang R; Yang WJ; Liu Y; Ma YM; Gong SQ; Zhang SM; Ren Q; Han XY; Ji LN
Zhonghua Nei Ke Za Zhi; 2021 May; 60(5):438-445. PubMed ID: 33906273
[No Abstract] [Full Text] [Related]
19. Regression and progression of microalbuminuria in adolescents with childhood onset diabetes mellitus.
Son MK; Yoo HY; Kwak BO; Park HW; Kim KS; Chung S; Chae HW; Kim HS; Kim DH
Ann Pediatr Endocrinol Metab; 2015 Mar; 20(1):13-20. PubMed ID: 25883922
[TBL] [Abstract][Full Text] [Related]
20. Albuminuria in chronic heart failure: prevalence and prognostic importance.
Jackson CE; Solomon SD; Gerstein HC; Zetterstrand S; Olofsson B; Michelson EL; Granger CB; Swedberg K; Pfeffer MA; Yusuf S; McMurray JJ;
Lancet; 2009 Aug; 374(9689):543-50. PubMed ID: 19683640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
